Combination of chemotherapy and interferon alfa-2b in the treatment of chronic myelogenous leukemia.
Freund
M
M
Abteilung für Hämatologie und Onkologie Medizinische Hochschule Hannover, Germany.
Hild
F
F
Grote-Metke
A
A
Nowak
R
R
Otremba
B
B
Wörmann
B
B
Koch
O
O
Dohmen
M
M
Kleine
H D
HD
Link
H
H
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002066:Busulfan / Q000008:administration & dosage; D003561:Cytarabine / Q000008:administration & dosage; D005260:Female; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D011994:Recombinant Proteins; D012074:Remission Induction
D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D003561:Cytarabine; D002066:Busulfan